The Cancer Center at Illinois Cancer Technology and Data Science Program will host a workshop on IRB compliance featuring Sarah Mumford, Director of the Office of the Protection of Research Subjects.
Abstract:
With the growth of research at the University of Illinois Urbana-Champaign and the focus on innovations in healthcare, Illinois is focusing on improvements to its oversight of human subject research via improved compliance, increased efficiency of review, and expanded tools and resources. One area of particular interest is research involving FDA-regulated products. For example, the FDA definition of human subject research requiring IRB oversight is different from the DHHS definition of human subject research that governs the majority of projects. Without appropriate consultation and discussions with the IRB early on, researchers can find they have unknowingly run afoul of FDA regulations resulting in the inability to utilize data for publication or support for future projects. Often, the process can be easier for researchers than anticipated if set up correctly in advance.
Speaker: Sarah Mumford, MBA, CIP
Sarah Mumford, MBA, CIP, is the Director of the Office for the Protection of Research Subjects at the University of Illinois Urbana-Champaign. She started at Illinois in 2022 and has overseen the development and implementation of the IRBOnline system as well as the re-design of the IRB review process with a focus on updated resources for researchers. Previously, Sarah worked at the University of Utah IRB for over ten years, having worked in all aspects of IRB review, management, and institutional compliance activities. In that role she was funded by NCATS and NICHD to operationalize the single IRB review process and educate investigators as part of several NIH-funded networks. Prior to her IRB work, Sarah worked in pediatric orthopedic research at a large children’s hospital and managed the legal, financial, and regulatory work for the Pediatric Spine Foundation. She also worked in product development for a major medical device manufacturer specializing in Class III devices. She has a BS in Accounting and an MBA from Purdue University.
